Eris Lifesciences Limited is an Indian company that specializes in the manufacturing, marketing, and distribution of pharmaceutical products. The company offers a wide range of branded formulations in various therapeutic areas including cardiovascular, anti-diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics. Additionally, Eris Lifesciences Limited also provides products in the fields of in-vitro fertilization, cosmetology, and dermatology. The company was established in 2007 and is headquartered in Ahmedabad, India.
Navigation section
Eris Lifesciences Limited
- 1,431.20 13.10(0.92%) 1,441.40 22.65(1.60%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 1,409.55 1,403.00 | 1,464.00 1462.15 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 809.15 (13-Mar-2024) 810.10 (13-Mar-2024) | 1,522.05 (06-Sep-2024) 1,521.05 (06-Sep-2024) |
- Open
- 1,414.50 1,417.70
- Previous Close
- 1,418.10 1,418.75
- Volume
- 3.05
- Total Traded value
- 43.65 (₹ Lakhs)
- Upper circuit
- 1,701.70 1,099.20
- Lower circuit
- 1,134.50 732.80
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 610 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 1,440.15 | 610.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 610 |
Fundamentals
| Market Cap: | ₹194.79 Cr |
| PE Ratio (TTM): | 166.03 |
| PB Ratio: | 7.49 |
| Industry P/E: | 52.61 |
| Debt to Equity: | - |
| ROE: | 4.51 |
| EPS (TTM): | 8.55 |
| Book Value: | 102.57 |
| Face Value: | 1.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 409.71 Cr | 411.29 Cr | 314.58 Cr | 332.01 Cr | 355.37 Cr |
| Profit | 117.81 Cr | 110.74 Cr | 87.84 Cr | 99.38 Cr | 115.20 Cr |
| Expense | 296.76 Cr | 282.79 Cr | 223.33 Cr | 225.26 Cr | 237.71 Cr |
| Comprehensive income | 115.79 Cr | 110.81 Cr | 88.38 Cr | 99.15 Cr | 115.00 Cr |
| EPS | 8.65 | 8.13 | 6.43 | 7.31 | 8.46 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Eris Lifesciences Limited | Jun, 2017 Jun, 2017 | Pharmaceuticals Pharmaceuticals | ERIS ERIS |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Eris Lifesciences Limited FAQ's
What is the range of today's stock performance for Eris Lifesciences Limited?
Today's stock performance witnessed a fluctuation from a minimum of 1,409.55 on the NSE (National Stock Exchange) to a maximum of 1,464.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,403.00 to a high of 1,462.15.
What are the 52-week low and high values for Eris Lifesciences Limited?
The stock's performance over the past 52 weeks reveals a low of 809.15 (occurred on 13-Mar-2024) and a high of 1,522.05 (achieved on 06-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 810.10 (on 13-Mar-2024), and the 52-week high is 1,521.05 (on 06-Sep-2024).
What was the opening and previous closing prices for Eris Lifesciences Limited?
The stock's performance over the past 52 weeks reveals a low of 809.15 (occurred on 13-Mar-2024) and a high of 1,522.05 (achieved on 06-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 810.10 (on 13-Mar-2024), and the 52-week high is 1,521.05 (on 06-Sep-2024).
What is the total volume and traded value for Eris Lifesciences Limited for the day?
The total volume is 3, and the total traded value is 43.65 (₹ Lakhs).
What are the upper and lower circuit limits for Eris Lifesciences Limited?
The upper circuit limit is 1,701.70, and the lower circuit limit is 1,134.50.
What is the market cap and PE ratio for Eris Lifesciences Limited?
The market cap is ₹194.79 Cr, and the PE ratio (TTM) is 52.61.
What is the PB ratio, industry P/E, and debt to equity ratio for Eris Lifesciences Limited?
The PB ratio is 13.95, industry P/E is 52.61 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Eris Lifesciences Limited?
ROE is 4.51, EPS is 8.55, book value is 102.57
What are the revenue and profit figures for the latest quarter and previous quarters for Eris Lifesciences Limited?
In Sep 2023, Revenue is ₹4097090000.00, and Profit is ₹1178070000.00. In Jun 2023, Revenue is ₹4112870000.00, and Profit is ₹1107420000.00.
When was Eris Lifesciences Limited listed, and what industry does it belong to?
The company, Eris Lifesciences Limited, was listed in Jun 2017 and belongs to the Pharmaceuticals industry. Its NSE symbol is ERIS.
What is the current shareholding pattern of the Eris Lifesciences Limited?
As of latest available update, promoters hold 54.91%, the public holds 45.09%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 25
- Threads
- 81
